---
id: wfsbp-anxiety-ocd-ptsd-2025
title: "WFSBP 2025 Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive, and Post-Traumatic Stress Disorders â€“ First Revision"
short_title: "WFSBP Anxiety/OCD/PTSD 2025"

organization: World Federation of Societies of Biological Psychiatry
collaborators: null
country: Global
url: https://www.wfsbp.org/treatment-guidelines/
doi: null
pmid: null
open_access: true

specialty: psychiatry
guideline_type: clinical-practice
evidence_system: WFSBP
conditions:
  - generalized anxiety disorder
  - panic disorder
  - social anxiety disorder
  - obsessive-compulsive disorder
  - post-traumatic stress disorder
tags:
  - SSRIs
  - SNRIs
  - pregabalin
  - benzodiazepines
  - psychopharmacology

publication_date: 2025-08-09
previous_version_date: 2008-01-01
status: current
supersedes: null
superseded_by: null

pdf_path: null
has_pdf: false
last_reviewed: 2025-12-23
---

## Scope
First major revision of the WFSBP guidelines for the biological treatment of anxiety disorders, OCD, and PTSD, incorporating a wide body of evidence accumulated since the original 2002-2008 publications.

## Key Recommendations

### Generalized Anxiety Disorder (GAD)
- **First-Line**: SSRIs (e.g., escitalopram, paroxetine, sertraline), SNRIs (e.g., duloxetine, venlafaxine), or pregabalin.
- **Second-Line**: Buspirone, quetiapine XR, or benzodiazepines (short-term due to dependence risk).

### Panic Disorder
- **First-Line**: SSRIs (e.g., escitalopram, citalopram, paroxetine, sertraline) or venlafaxine XR.
- **Augmentation**: Benzodiazepines (e.g., alprazolam, clonazepam) may be used short-term at the start of treatment to manage acute symptoms while waiting for SSRI/SNRI onset.

### Social Anxiety Disorder (SAD)
- **First-Line**: SSRIs (e.g., escitalopram, paroxetine, sertraline) or venlafaxine XR.
- **Alternative**: Pregabalin.
- **PRN for Performance Anxiety**: Beta-blockers (e.g., propranolol) are not recommended for generalized SAD but may help for specific performance situations.

### Obsessive-Compulsive Disorder (OCD)
- **First-Line**: SSRIs at high doses (often higher than those used for depression).
- **Second-Line/Augmentation**: If SSRIs fail, add low-dose antipsychotics (e.g., risperidone, aripiprazole) as augmentation.
- **Clomipramine**: An alternative first-line, though often reserved for SSRI non-responders due to side effect profile.

### Post-Traumatic Stress Disorder (PTSD)
- **First-Line**: SSRIs (e.g., sertraline, paroxetine) or venlafaxine.
- **Nightmares**: Prazosin (an alpha-1 blocker) may be used as an adjunct for trauma-related nightmares.
- **Benzodiazepines**: Not recommended for PTSD due to lack of efficacy and risk of worsening outcomes.

### General Notes
- Psychotherapy (e.g., CBT, exposure therapy) should be offered in conjunction with pharmacotherapy for all disorders.
